Breast International Group
Events
Research achievements
Move for BIG
The Breast International Group is proud to adhere to the Code of Ethics of the VEF-AERF
The Breast International Group is proud to adhere to the Code of Ethics of "de Vereniging voor Ethiek in de Fondsenwerving (VEF)" / "l’Association pour une Ethique dans les Récoltes de Fonds (AERF)”.
This Belgian not-for-profit brings together national, international and non-governmental associations and ensures that its members respect a Code of Ethics in the use and collection of funds from private donors.
The association also requires its members to meet various obligations on a regular basis to verify the commitments they have made.
In concrete terms, this means that: "Breast International Group - aisbl adheres to the VEF-AERF code of ethics. You have a right to be informed. This implies that donors, collaborators, volunteers and employees are informed at least annually about the use of the funds collected.”
News highlights
APHINITY Press Release 2022
8-year APHINITY study data: further reduction in breast cancer recurrence risk or death..
Read moreNew issue of BIG Research in Focus available
This edition highlights the OlympiA Trial: a new hope for women and men with BRCA mutations...
Read moreA message from Breast International Group's Honorary President
Finding a cure is one of the biggest challenges faced by researchers from around the world. Breast cancer affects women and men of all ages. This is why prevention is crucial. When breast cancer is diagnosed, the impact on a patient’s life and loved ones is devastating and causes intense stress. Appropriate psychological and moral support is needed and can really make a big difference.
It is crucial to identify the most appropriate and personalised therapies to increase the chances of recovery and cure. BIG fosters collaboration among the world's leading experts in breast cancer and advances research. This is essential to give hope to everyone concerned. - HRM the Queen of the Belgians, Honorary President of Breast International Group
A message from BIG against breast cancer's President
There are many areas of research that hold great promise for patients but have no particular interest for commercial partners.
That is why BIG develops and runs academic studies that hold tremendous potential for patients and promise long-term gains for society, in all regions of the world. Thanks to our global network of breast cancer experts, we can run these trials more efficiently.
- Martine Piccart, Co-founder and President of BIG against breast cancer
